Immune checkpoint inhibitors have reshaped cancer care, yet they may also lead to uncommon but serious neurological complications. Join the 2nd Edition of International Conference on Neurology and Neuroscience (Neuro Care-2027), taking place March 22–24, 2027 in Singapore and Online, where international experts will present the latest advances in neurological science and clinical practice.
📍 Featured Conference
Talk:
"Neurological complications of immune check point inhibitor therapy: A report of
two cases from Canada".
👨⚕️ Speaker Profile:
Dr. Joseph Y. Chu
University of Toronto, Canada
🔎 Key Discussion
Points:
- Identifying
neurological side effects associated with immune checkpoint inhibitor
therapy
- Reviewing
two Canadian clinical case reports
- Understanding
diagnostic difficulties in immune-related neurotoxicity
- Exploring
treatment options and patient care strategies
- Emphasizing
the value of early recognition and team-based care
- Weighing
cancer treatment benefits against neurological risks
- Encouraging
further research on immunotherapy-related adverse events
🌍 Conference Website:
https://neurocareconference.com/
📝 Abstract Submission:
https://neurocareconference.com/abstract-submission
▶️ Scientific Sessions &
Conference Updates:
https://www.youtube.com/@MathewsInternationalLLC
Join neurologists, oncologists, researchers, and healthcare
professionals as we examine the evolving understanding of immune checkpoint
inhibitor-related neurological complications and their impact on patient care
and clinical decision-making.
No comments:
Post a Comment